Actifed Compound

Quick links to important sections

Actifed Compound

Method of action: Antitussive Opioid

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Actifed Compound

Quick Facts

Property Description
Active Ingredients Codeine, Pseudoephedrine, Triprolidine
Form Oral solution or Syrup
Pharmacological Class Antitussive, Nasal Decongestant, First-Generation Antihistamine
Common Use Simultaneous relief of cough, congestion, and allergic symptoms
Origin Mixed (Semi-synthetic and Synthetic compounds)

Actifed Compound is defined as a fixed-dose combination product within the general class of Upper Respiratory Combination medications, formulated for the concurrent relief of symptoms associated with the common cold and allergies. This preparation's identity is established by the simultaneous activity of its three distinct active ingredients: an antitussive, a nasal decongestant, and a first-generation antihistamine.

What Type of Medicine is Actifed Compound?

The preparation belongs to the triple pharmacological class encompassing an Antitussive (cough suppressant), a Nasal Decongestant (Alpha-Adrenergic Agonist), and a First-Generation Antihistamine (H1-antagonist). This specific combination is widely clinically recognized for its efficacy in managing the complex array of respiratory discomforts that often accompany viral illnesses. Its chemical composition defines it as a mixed-origin product: Codeine, the antitussive component, is a semi-synthetic derivative, while both Pseudoephedrine and Triprolidine are fully synthetic compounds. This particular formulation is known for its sedative effects due to the inclusion of Triprolidine and Codeine, differentiating it from newer, non-drowsy alternatives.

Composition and Form: What Active Ingredients Does It Contain?

The formulation contains the active ingredients Codeine (typically as the phosphate salt), Pseudoephedrine (typically as the hydrochloride salt), and Triprolidine (typically as the hydrochloride salt). This mixture is prepared for oral use and commonly presented as an oral solution or high-viscosity syrup, although tablet forms also exist. The liquid formulation utilizes an aqueous solution base, often incorporating agents such as sucrose or sorbitol to create the necessary syrup base/vehicle for stable suspension and palatable ingestion.

Actifed Compound's General Purpose

The general therapeutic purpose of Actifed Compound is the comprehensive and simultaneous mitigation of three key symptomatic pathways: cough, congestion, and allergic discharge. The combination of these three agents is an established method for multi-symptom relief from conditions like allergic rhinitis and the common cold. This multi-action capability ensures that symptoms like a persistent cough, nasal congestion, and running nose are addressed together, offering integrated relief tailored for instances where a patient experiences simultaneous persistent coughing and upper respiratory obstruction.

Regulatory References

  1. Codeine: MedlinePlus Drug Information

What side effects are possible with Actifed Compound?

Possible Side Effects and Safety Information

The safety profile for Actifed Compound, a combination of Codeine, Pseudoephedrine, and Triprolidine, is documented in official government regulatory labels based on frequency and affected physiological systems.

Frequency and System-Organ Classes

The most frequent adverse reactions relate primarily to the central nervous system (CNS) and anticholinergic activity. Sedation and drowsiness are classified as Very Common. Common effects include nervousness, insomnia, dizziness, dry mouth, nausea, and vomiting. Rare effects include hallucinations, tachycardia, palpitations, and increased blood pressure. Adverse effects are grouped under classes such as Nervous System Disorders, Psychiatric Disorders, Vascular Disorders, and Gastrointestinal Disorders.

Documented Serious Adverse Reactions

The product's regulatory labels include documentation of serious but low-frequency safety risks. These include severe skin reactions like Acute Generalized Exanthematous Pustulosis (AGEP), and serious vascular events. Cases of Posterior Reversible Encephalopathy Syndrome (PRES) and Reversible Cerebral Vasoconstriction Syndrome (RCVS) have been reported. The Codeine component carries a risk of life-threatening respiratory depression.

Population-Specific Constraints

Specific restrictions define the safety boundaries for use. The medicine is contraindicated for children younger than 12 years of age. Older adults are noted to be more susceptible to CNS effects such as confusion and urinary retention. Furthermore, the product is contraindicated in individuals with severe uncontrolled hypertension, severe coronary artery disease, or severe renal or hepatic impairment.

Overdose and Emergency Response

Actifed Compound overdose is defined by the combined toxicological risks of its three active ingredients. The most severe manifestation documented in regulatory materials is life-threatening respiratory depression, primarily linked to the Codeine component. Overdose may also present with conflicting clinical signs, including profound somnolence or confusion (CNS depression) as well as excitation, seizures, or hallucinations (CNS stimulation). Other officially documented manifestations include slow heartbeat, fixed dilated pupils, and cold, clammy skin.

Immediate action is mandated by regulatory authorities. The official label requires individuals to seek medical attention immediately or to get emergency help at once for any suspected overdose. Urgent intervention is critical due to the documented risk of fatal outcome, especially from accidental ingestion by children. Specific warnings note that children are at high risk of toxicity and that ultra-rapid metabolizers of Codeine are at risk of overdose due to elevated morphine levels. Overdose management is officially defined as symptomatic and supportive treatment, with the option to consider Naloxone for respiratory compromise related to the opioid component.

Therapeutic Uses of Actifed Compound

What Actifed Compound Treats: Main Uses and Benefits

Actifed Compound is designed for use during symptomatic episodes, offering supportive relief across multiple symptom domains associated with respiratory illnesses and allergies. The therapeutic domain is aligned with the indications for symptomatic relief of coughs associated with the common cold or allergy. It is applied in contexts where a patient requires temporary assistance in managing combined, disruptive manifestations.


Integrated Symptom Relief

This medication is commonly used across conditions presenting with acute episodes that require a cluster of symptoms to be managed simultaneously. It is relevant for easing challenging symptoms of nasal obstruction and sinus pressure, controlling allergic discharge (such as sneezing and runny nose), and suppressing the dry, irritative cough. This comprehensive approach assists with maintaining functional stability when symptoms interfere with routine activities.

“It is commonly used when multiple symptoms occur together, requiring a combined approach to easing patient distress.”

Quick Fact: Supports Management of Combined Symptoms
Symptom Focus Cough, congestion, and allergic discharge
Common Contexts Acute cold or seasonal allergy flare-ups
Patient Benefit Supports the patient during difficult episodes by easing overall symptom burden

Regulatory References

  1. Health Canada Product Monograph

Eligibility and Restrictions for Use

The eligibility to use Actifed Compound, a combination of Codeine, Pseudoephedrine, and Triprolidine, is strictly defined by regulatory warnings and contraindications based on patient population.

Contraindicated Populations (Must Not Use)

Category Absolute Exclusion Restriction Details
Age Children younger than 12 years of age; young people under 18 years following tonsillectomy/adenoidectomy. Generally not recommended for cough suppression under 18 years in many regions.
Physiological Status Women who are breastfeeding; patients known to be CYP2D6 ultra-rapid metabolizers. Not recommended during pregnancy due to lack of established safety.
Comorbidities Patients with severe hypertension or severe coronary artery disease; patients with severe renal impairment. Contraindicated in conditions like phacochromocytoma or closed-angle glaucoma.
Drug Use Patients currently taking, or who have taken, Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days. Contraindicated with other sympathomimetic decongestants.

Restricted/Conditional Use

Use requires caution in the elderly due to heightened sensitivity to effects like confusion. Caution is also warranted for patients with mild-to-moderate renal or hepatic impairment, prostatic hypertrophy, diabetes mellitus, or controlled hypertension.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of Actifed Compound is primarily derived from the combined pharmacological activities of its three components: Codeine, Pseudoephedrine, and Triprolidine. All interaction information is based on official government regulatory labeling.


Formally Contraindicated Combinations

Co-administration with certain substances is strictly prohibited due to severe adverse reaction risks, requiring a mandatory non-use period:

  • Monoamine Oxidase Inhibitors (MAOIs): Use during or within 14 days of stopping MAOI therapy is contraindicated due to the risk of hypertensive crisis (from Pseudoephedrine) and severe CNS effects.
  • Ergot Derivatives (e.g., Ergotamine): Prohibited due to the risk of additive vasoconstriction, which may elevate blood pressure.
  • CYP2D6 Ultra-Rapid Metabolizers: Use is contraindicated in patients identified with this phenotype due to an increased risk of opioid toxicity from Codeine’s rapid metabolism.

Significant Pharmacodynamic and Metabolic Interactions

Interaction Type Interacting Agent(s) Regulatory Caution
CNS Depression Alcohol (Ethanol), Other Opioids, Sedatives, Anxiolytics Risk of profound sedation, respiratory depression, and coma due to additive effects.
Metabolic Risk CYP2D6/CYP3A4 Inhibitors May alter Codeine’s plasma levels, potentially reducing efficacy (CYP2D6 inhibition) or increasing exposure (CYP3A4 inhibition).
Pharmacodynamic Serotonergic Drugs (e.g., SSRIs) Increased risk of Serotonin Syndrome.
Antihypertensives Antihypertensive Drugs Pseudoephedrine may reduce the blood pressure-lowering effects.

Mechanism of Action

The mechanism of action for the components of Actifed Compound involves two distinct pharmacological pathways.

The antihistamine, triprolidine, acts as an inverse agonist at the histamine mathbfH1 receptor. This antagonism stabilizes the receptor's inactive conformation, resulting in the inhibition of mathbfH1 receptor-mediated signal transduction in the periphery.

The decongestant, pseudoephedrine, is an agonist primarily at mathbfalpha1-adrenergic receptors located on the vascular smooth muscle of the nasal mucosa. Activation of these receptors induces vasoconstriction. This action reduces local blood flow, thereby decreasing mucosal edema and cellular infiltration. The combination utilizes both mathbfH1 receptor antagonism and mathbfalpha-adrenergic receptor agonism to exert its physiological effects.

Dosage and Administration Information

How to Use Actifed Compound

This section outlines the administration instructions for Actifed Compound (Codeine, Pseudoephedrine, and Triprolidine). These instructions define the dose, frequency, and duration of use.

Administration and Dosage

The preparation is for oral administration, typically dispensed as a liquid or syrup. The dosing is structured according to the patient's age and is based on a standard regimen:

Age Group Single Dose (Syrup) Maximum Frequency Maximum Duration
Adults and Adolescents (greater than or equal to 12 years) 10 mL Every 4 to 6 hours Not to exceed 7 days
Children 6 to 11 years 5 mL Every 4 to 6 hours Not to exceed 7 days

The maximum recommended intake is 4 doses within any 24-hour period.

Instructions for Proper Use

To ensure accurate administration, the following procedural steps are required for the oral solution:

  • Preparation: The bottle containing the syrup must be shaken well immediately before each use.
  • Measurement: The dose must be measured precisely using the measuring device provided with the product to ensure the correct volume is taken.
  • Dosing Interval: Doses must be spaced with a minimum interval of 4 hours to avoid exceeding the daily maximum limit.

Use in Specific Populations

While standard adult dosage may be applied to older adults, caution is generally advised due to potential age-related sensitivity to the combination's effects. Use in children under 6 years is often contraindicated or not recommended.

Course Duration

Actifed Compound is intended for short-term use only. The medication should not be used for more than 7 days; consultation with a healthcare professional is necessary if symptoms continue beyond this period.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Actifed Compound

Evidence for Use in Allergic Rhinitis

Research examining the combination of a decongestant and an antihistamine, often referred to as Actifed Compound, has primarily involved randomized controlled trials (RCTs). These studies were conducted during periods of increased symptom activity and focused on conditions characterized by fluctuating or episodic manifestations, such as allergic rhinitis. Researchers employed various methods, including the use of patient-reported outcomes describing perceived discomfort, to study temporary symptom patterns. Outcomes related to physical discomfort, such as sneezing, runny nose, and itchy/watery eyes, were measured in research exploring short-term symptom changes.

Findings reflect patterns observed in the studies where this combination was studied alongside changes measured during the study period. Studies report how symptoms were monitored in the observed populations, sometimes reporting a measurement of change in outcomes linked to inflammatory or irritative states compared to a placebo. However, the results apply only to the specific populations studied, and findings were sometimes mixed regarding the precise magnitude of these changes.

Evidence for Use in Common Cold Symptoms

The combination of ingredients was also studied in research exploring symptoms associated with the common cold or influenza, which are conditions involving periods of heightened symptoms. Research monitored how certain cold-related symptoms, such as a blocked nose, changed over the study period, particularly in relation to outcomes capturing phases of heightened symptom activity. Studies help show what has been observed so far, researching the combination in relation to acute or disruptive episodes.

What is Still Uncertain about Actifed Compound

Research focusing specifically on the long-term effects and follow-up beyond the typical course of acute treatment is limited. Most available evidence describes symptom changes that were monitored over defined, short time intervals, consistent with the short-term focus of the research. This means that the durability of any observed changes following the cessation of use is not fully established. Comparative evidence is limited regarding the combination against many other alternatives, and the evidence base for pediatric and geriatric populations remains insufficient.

Key Studies & References

  1. Decongestants and antihistamines for the common cold: a review of the evidence

Frequently Asked Questions (FAQ)

Common questions about Actifed Compound (FAQ)

Q: Can Actifed Compound be taken at night?

Official drug information reports that this medication commonly causes sedation and drowsiness, which are Very Common side effects. Due to these effects, the product is sometimes used at night, but official warnings highlight that these effects can impair alertness and coordination.

Q: Does Actifed Compound interact with common pain relievers?

Regulatory sources generally caution against taking this product with other cold and flu remedies that may contain similar ingredients. However, common non-opioid pain relievers, such as paracetamol (acetaminophen) or ibuprofen, are generally not listed as formal contraindications in the drug’s official regulatory labels.

Q: Are there any foods or drinks to avoid while taking Actifed Compound?

Official labeling advises against consuming alcohol (ethanol) while using this medication. This is due to the potential for increased central nervous system depression, which can lead to severe drowsiness or respiratory problems. Specific non-alcoholic food interactions are not generally listed as formal contraindications in the drug's official documents.

Q: Can Actifed Compound be taken with other cold and flu medicines?

Official product information warns against using this medicine with other products that contain similar ingredients, such as other antihistamines, decongestants, or cough suppressants. Combining these products carries a risk of exceeding the recommended maximum dose for the active components and increasing the likelihood of adverse effects.

Q: Does Actifed Compound have potential for misuse or dependence?

The Codeine component of Actifed Compound is an opioid. Regulatory labels for opioid-containing products typically include warnings that the drug may be habit-forming. Regulatory warnings state that there is potential for physical dependence and misuse when the medication is used outside recommended guidelines or for prolonged periods.

Q: Can Actifed Compound affect driving or operating machinery?

Regulatory documents explicitly state that this medicine may cause drowsiness, dizziness, and psychomotor impairment. These effects can impact a person’s ability to drive or safely operate machinery. Patients are typically advised to establish their individual response to the medication before engaging in such activities.

Q: Is it true Actifed Compound is restricted in some places?

The legal classification of Actifed Compound is subject to varying regulatory control in different countries. Due to the presence of Codeine and Pseudoephedrine, the product is often subject to control mechanisms. The control mechanisms include requirements for sale exclusively through a licensed pharmacist or classification as a prescription medicine.

Q: Does Actifed Compound contain a stimulant?

One of the active ingredients, Pseudoephedrine, is pharmacologically classified as a sympathomimetic agent, which has stimulating effects. Regulatory warnings indicate that it can cause symptoms such as nervousness and insomnia, particularly if recommended dosage limits are exceeded.

Q: Is Actifed Compound used for sinus pain or pressure?

The medication is officially indicated for the relief of nasal congestion and upper respiratory symptoms. Regulatory labels specify that the decongestant component, Pseudoephedrine, works to reduce swelling in the nasal passages. This action is the mechanism generally associated with alleviating symptoms of sinus pressure.

Q: Are there official research findings about Actifed Compound I can read?

Official scientific data and research summaries used to support the drug’s approval are generally contained within its formal regulatory documents. These documents, such as the Summary of Product Characteristics or the FDA Label, are typically accessible via government health authority websites for public review.

Q: What are the inactive ingredients in Actifed Compound?

Official drug labels list the inactive ingredients, also called excipients, used in the formulation. For liquid forms, common inactive components include a sweetening agent like sucrose or sorbitol to create the syrup base, as well as coloring, flavorings, and preservatives.

Q: Is Actifed Compound the same as plain Actifed?

The term 'Actifed Compound' refers specifically to the combination product containing three active ingredients: Codeine, Pseudoephedrine, and Triprolidine. Other products marketed under the 'Actifed' name generally contain Pseudoephedrine and Triprolidine but often exclude the Codeine component.

Q: How quickly does Actifed Compound usually start working?

Regulatory documents indicate that the decongestant component, Pseudoephedrine, typically begins to produce its effect within 30 minutes of being taken orally. The antihistamine component, Triprolidine, usually has an onset of action documented within 1 to 2 hours.

Q: How long do the effects of Actifed Compound typically last?

The product is designed to be administered at intervals of 4 to 6 hours, which corresponds to the typical duration of action for the combined ingredients. Official documentation indicates that the antihistamine component’s significant activity can persist for at least 8 hours after a single dose.

Q: Is Actifed Compound available over-the-counter?

Due to the inclusion of Codeine and Pseudoephedrine, the product’s legal classification in many regions is typically a 'Pharmacy Medicine.' This designation means the product is not available on general retail sale and must be purchased from a licensed pharmacist.

Q: Is Actifed Compound a prescription-only medicine?

While the product is classified as 'Prescription-Only Medicine' (POM) in some regions, its classification often falls under 'Pharmacy Medicine' (P) in others. When classified as a P medicine, it requires supervision by a pharmacist but does not necessarily require a physician’s prescription.

Q: Is Actifed Compound known to cause rebound congestion?

Rebound congestion, also known as Rhinitis Medicamentosa, is a condition generally associated with the prolonged use of topical (nasal spray) decongestants. Regulatory information for the oral decongestant Pseudoephedrine component in this product does not specifically list rebound congestion as a known adverse effect.

Q: What is the difference between Actifed Compound and Sudafed?

Official documentation establishes that Actifed Compound is a fixed-dose combination containing Codeine, Pseudoephedrine, and Triprolidine. Products marketed under the Sudafed name are commonly associated with a single active ingredient, Pseudoephedrine, a nasal decongestant.

Q: Is there a generic version of Actifed Compound available?

Regulatory approval data confirms that the combination of the three active ingredients (Codeine, Pseudoephedrine, Triprolidine) is available in generic equivalents. These products must meet the same quality, stability, and efficacy standards as the branded product according to regulatory authorities.

Q: What should I do if I miss a scheduled dose of Actifed Compound?

Official patient guidance typically recommends that a missed dose may be taken as soon as the patient remembers, provided it does not interfere with the next scheduled dose. If it is almost time for the next dose, the missed dose should be skipped entirely to prevent taking a double dose.

Q: Can people with thyroid problems use Actifed Compound?

Official warnings and precautions commonly advise caution or consultation for patients diagnosed with thyroid problems, particularly hyperthyroidism. The Pseudoephedrine component is noted to potentially cause cardiovascular effects that could be exacerbated in this specific condition.

Q: Is Actifed Compound safe to use with herbal supplements?

Official drug labels generally do not provide a comprehensive list of herbal supplements. However, they typically warn about interactions with substances that have central nervous system depressant or stimulating effects, which can apply to certain herbal remedies. Patients are advised to consult on all concurrent use.

How should Actifed Compound be stored and disposed of?

Storage and Disposal of Actifed Compound

Storage of Actifed Compound must strictly adhere to regulatory requirements to maintain product stability and safety.

Official Storage Conditions

Requirement Specific Condition
Temperature Store below 25°C.
Protection Must be stored in the original package to protect it from light and moisture.
Freezing Liquid formulations must be kept from freezing.
Child Safety Keep this medicine out of the sight and reach of children.
Shelf-Life Do not use after the expiry date.

Disposal Instructions

Official instructions prohibit disposal of Actifed Compound via wastewater or household waste. Any unused or expired product must be disposed of in accordance with local pharmaceutical waste requirements. Patients are directed to consult a pharmacist for guidance on proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Actifed Compound found in:

A-Z Index: